Regulatory Pathways for Cell and Gene Therapies: Balancing Innovation with Compliance

被引：0
|
作者：
Bernard, Claire [1 ]
机构：
[1] Institute of Biotechnology, Université de Bordeaux, Bordeaux, France
来源：
Journal of Commercial Biotechnology | 2024年 / 29卷 / 06期
关键词：
Compilation and indexing terms; Copyright 2025 Elsevier Inc;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Disease control - Diseases - Regenerative medicine
引用
收藏
页码：136 / 144
相关论文
共 50 条
  • [1] Regulatory Frameworks for Gene and Cell Therapies in Japan
    Maeda, Daisuke
    Yamaguchi, Teruhide
    Ishizuka, Takami
    Hirata, Masakazu
    Takekita, Kazuhiro
    Sato, Daisaku
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 147 - 162
  • [2] Proceedings: International Regulatory Considerations on Development Pathways for Cell Therapies
    Feigal, Ellen G.
    Tsokas, Katherine
    Viswanathan, Sowmya
    Zhang, Jiwen
    Priest, Catherine
    Pearcee, Jonathan
    Mount, Natalie
    STEM CELLS TRANSLATIONAL MEDICINE, 2014, 3 (08) : 879 - 887
  • [3] Global Regulatory Differences for Gene- and Cell-Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation
    Coppens, Delphi G. M.
    De Bruin, Marie L.
    Leufkens, Hubert G. M.
    Hoekman, Jarno
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 120 - 127
  • [4] Biosafety testing of cell and gene therapies; rapid methods and regulatory expectations
    Sheridan, S.
    Spreng, K.
    McKee, M.
    Goodier, R.
    HUMAN GENE THERAPY, 2019, 30 (08) : A29 - A29
  • [5] Regulatory framework for innovation assessment in advanced therapies in Europe
    Ponce-Polo, A.
    Ritore-Hidalgo, A.
    Oruezabal-Guijarro, R. I.
    HUMAN GENE THERAPY, 2019, 30 (11) : A207 - A207
  • [6] The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies
    Marco T. Sabatini
    Mark Chalmers
    Pharmaceutical Medicine, 2023, 37 : 365 - 375
  • [7] The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies
    Sabatini, Marco T.
    Chalmers, Mark
    PHARMACEUTICAL MEDICINE, 2023, 37 (5) : 365 - 375
  • [8] Regulatory and health technology assessment of cell and gene therapies in Europe: Convergence or divergence?
    Hoogendoorn, Mark
    Fabriek, Babs
    Bloem, Lourens T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 16 - 16
  • [9] Bringing gene and cell therapies from lab to patients: the EuroGCT research pathways
    Delage-Cazorla, A.
    Gilbert, L-S
    Kuo, H-Y
    Lorigan, J.
    Blackburn, C.
    Couturier, A.
    Waite, A.
    Mahalatchimy, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A194 - A194
  • [10] Regulatory Considerations for Cell Based Therapies
    Jones, D. R.
    TOXICOLOGY LETTERS, 2021, 350 : S36 - S36
12345